KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Assets: 2017-2024

Historic Assets for Moderna (MRNA) over the last 8 years, with Dec 2024 value amounting to $14.1 billion.

  • Moderna's Assets fell 23.21% to $12.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 billion, marking a year-over-year decrease of 23.21%. This contributed to the annual value of $14.1 billion for FY2024, which is 23.25% down from last year.
  • Per Moderna's latest filing, its Assets stood at $14.1 billion for FY2024, which was down 23.25% from $18.4 billion recorded in FY2023.
  • In the past 5 years, Moderna's Assets registered a high of $25.9 billion during FY2022, and its lowest value of $7.3 billion during FY2020.
  • In the last 3 years, Moderna's Assets had a median value of $18.4 billion in 2023 and averaged $19.5 billion.
  • Its Assets has fluctuated over the past 5 years, first soared by 361.61% in 2020, then declined by 28.74% in 2023.
  • Over the past 5 years, Moderna's Assets (Yearly) stood at $7.3 billion in 2020, then surged by 236.23% to $24.7 billion in 2021, then grew by 4.82% to $25.9 billion in 2022, then fell by 28.74% to $18.4 billion in 2023, then dropped by 23.25% to $14.1 billion in 2024.